Investing.com -- Viatris Inc. (NASDAQ: VTRS) stock fell 3.6% after the company announced that its Phase 3 study of MR-139 for blepharitis did not meet its primary endpoint. The randomized, double ...

Keros will also be eligible to receive tiered royalties on net sales. About the Elritercept Phase 3 RENEW Clinical Trial The elritercept Phase 3 RENEW clinical trial (NCT06499285) is a global, ...

Bristol Myers’ Reblozyl falls short in Phase 3; Blenrep voted down by FDA panel The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep’s return to the U.S. market got ...

Anlotinib plus penpulimab has demonstrated encouraging activity and safety in a phase 2 study. In this phase 3 trial, we aimed to assess whether the combination of anlotinib plus penpulimab improved ...

Long-acting injectable cabotegravir (Vocabria; ViiV Healthcare) and rilpivirine (Rekambys; ViiV Healthcare) (CAB+RPV) for use as antiretroviral therapy (ART) was preferred by patients in the phase ...

Key Phase 3 NEAT clinical trial enrollment highlights include: A total of 105 participants were enrolled, including 83 participants in the six to nine year-old primary analysis population and 22 ...